Witt, O., Chi, S. N., Kang, H. J., Ziegler, D. S., Baxter, P. A., Bailey, S., Driever, P. H., Leary, S., McCowage, G. B., Perreault, S., Waanders, A. J., Landi, D. B., Kilburn, L. B., Hansford, J., Khuong-Quang, D., Nysom, K., Bailey-Torres, A., Qiu, J., McLeod, L., Lugt, J. V. D. (2025). Post hoc analysis of rashes reported in patients (pts) with
            <i>BRAF</i>
            -altered relapsed/refractory (r/r) pediatric low-grade glioma (pLGG) treated with the type II RAF inhibitor tovorafenib in FIREFLY-1.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.10037